Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €76.51 EUR
Change Today 0.00 / 0.00%
Volume 0.0
LLY On Other Exchanges
New York
SIX Swiss Ex
Sao Paulo
As of 8:43 AM 07/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Enrique A. Conterno

Senior Vice President and President of Lilly Diabetes, Eli Lilly and Company
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

As of Fiscal Year 2014


Mr. Enrique A. Conterno has been President of Diabetes Business Unit at Eli Lilly & Company since November 1, 2009 and serves as its Senior Vice President. Mr. Conterno served as the Head of the diabetes business unit at Eli Lilly & Co. since November 1, 2009. He served as Leader of Diabetes Business Unit at Eli Lilly & Co. since November 1, 2009. Mr. Conterno served as President of Lilly USA, LLC at Eli Lilly & Co. from January 2009 to November 1, 2009. He served as ...

Read Full Background

Corporate Headquarters*

Lilly Corporate Center
Indianapolis, Indiana 46285

United States

Phone: 317-276-2000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.


MBA 1992
Duke University
Bachelor's Degree 1989
Case Western Reserve University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$682,890

Stock Options*

Restricted Stock Awards$1,500,000
All Other Compensation$40,973
Exercised Options7,101
Exercised Options Value$117,593
Exercisable Options6,928
Exercisable Options Value$88,748
Total Value of Options$206,340
Total Number of Options14,029

Total Compensation*

Total Annual Cash Compensation$1,159,205
Total Short Term Compensation$682,890
Other Long Term Compensation$1,540,973
Total Calculated Compensation$3,895,044
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LLY:FP €76.51 EUR 0.00


Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
Erez Vigodman Chief Executive Officer, President, Director and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELI LILLY & CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at